One Third of Malignant Pleural Mesothelioma Shows High Immunohistochemical Expression of MSLN or CXCR4 Which Indicates Potent Candidates for Endo-Radiotherapy

Malignant pleural mesothelioma (MPM) is a mainly asbestos-related tumour associated with a very poor prognosis. Therapeutic approaches include multimodal therapy and chemotherapeutics, with cisplatin being the drug of choice, but response rates of only up to 14% indicate very poor outcomes. Effectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hager, Thomas, Borchert, Sabrina, Wessolly, Michael, Mathilakathu, Alexander, Mairinger, Elena, Kollmeier, Jens, Mairinger, Thomas, Hegedus, Balazs, Greimelmaier, Kristina, Wohlschlaeger, Jeremias, Herrmann, Ken, Mairinger, Fabian Dominik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094643/
https://www.ncbi.nlm.nih.gov/pubmed/37047331
http://dx.doi.org/10.3390/ijms24076356

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094643/
https://www.ncbi.nlm.nih.gov/pubmed/37047331
http://dx.doi.org/10.3390/ijms24076356

Ejemplares similares